Almado, Inc.

Almado, Inc.

4932.T
Almado, Inc.JP flagTokyo Stock Exchange
693.00
JPY
+1.00
- -
6.41BMarket Cap
Almado, Inc.
4932.T
(Tokyo Stock Exchange)

Recent

price

693.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
228.54
314.42
577.88
453.43
532.69
671.92
791.07
917.98
- -
410.22
Revenue per Share
17.02
27.69
64.97
36.69
57.81
60.29
72.98
70.43
- -
58.66
Basic EPS, GAAP
-2.75
7.14
17.95
63.89
24.87
72.52
87.58
-28.15
- -
- -
Free Cash Flow per Basic Share
- -
37.62
- -
- -
- -
41.15
65.44
70.07
- -
- -
Dividend per Share
141.19
131.26
222.66
259.35
283.85
313.35
327.04
337.85
- -
255.13
Book Value per Share
114.32
104.45
190.61
227.57
263.85
237.34
195.7
200.1
- -
117.47
Tangible Book Value per Share
12
12
10
10
10
10
10
9
- -
9
Basic Weighted Avg Shares
2,754
3,789
5,796
4,548
5,365
6,529
7,539
8,477
10,119
3,792
Sales/Revenue/Turnover
20.76
12.13
16.99
11.59
15.58
12.74
12.74
11.16
6.77
19.45
Operating Margin (%)
24
25
28
21
17
16
16
32
26
- -
Depreciation Expense
205
334
652
368
582
586
695
650
518
542
Net Income, GAAP
32.48
27.14
33.69
31.48
30.4
30.02
27.8
30.56
24.84
26.75
Effective Tax Rate (%)
7.45
8.81
11.24
8.09
10.85
8.97
9.23
7.67
5.12
14.3
Profit Margin (%)
1,606
1,419
1,785
2,147
2,528
2,197
1,769
1,640
1,589
870
Working Capital
341
280
- -
3
2
1
- -
4
3
- -
LT Debt
1,417
1,298
1,949
2,317
2,688
2,332
1,884
1,874
1,819
1,109
Total Equity
- -
18.21
31.88
14.48
20.7
18.84
22.1
18.11
12.73
15.18
Return on Invested Capital (%)
- -
16.67
30.54
14.65
20.78
18.01
18.1
14.13
10.5
12.1
Return on Capital (%)
- -
20.33
34.16
15.22
21.33
19.85
22.57
20.86
16.84
21.98
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
1,001
- -
2,600
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
- -
9
Market Capitalization
15,082
11,970
9,428

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
3,674
- -
3,961
Cash, Cash Equivalents & STI
1,513
- -
1,229
Accounts Receivable, Net
670
- -
548
Inventories
1,115
- -
1,289
Total Current Liabilities
1,904
- -
3,091
Payables & Accruals
- -
- -
- -
ST Debt
1,001
- -
2,600
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-3.99%
-2.94%
Free Cash Flow
- -
-75.63%
-385.82%
Net Income, GAAP
- -
10.16%
-20.3%
Sales/Revenue/Turnover
- -
17.39%
19.36%
Total Cash Common Dividend
- -
- -
-7.26%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,066
1,681
2,026
1,766
7,539
2025
- -
- -
- -
- -
8,477
2026
- -
- -
- -
- -
10,119

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-4.84
- -
- -
- -
72.98
2025
- -
- -
- -
- -
70.43
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
65.44
2025
- -
- -
- -
- -
70.07
2026
- -
- -
- -
- -
- -
Business
Almado Inc (TSE:4932) plans, develops, sells cosmetics, supplements, and quasi-drugs derived primarily from eggshell membrane materials in Japan, with all production outsourced. Core products include skincare such as whitening serum, moisturizing eggshell membrane serum, wrinkle-reducing and firmness-enhancing creams, facial cleansing with electrolyzed water, brightening lotions, hyaluronic acid spicules, and beauty drinks; hair growth supplements; and other beauty foods under brands including TO-II, Ode series, CELLULA, Type III, AMF, and Almado La Dina; the company also provides original equipment manufacturing (OEM) services and wholesale. It operates through television shopping channels such as QVC, external indirect sales to drug stores, hairdressers, and mail order firms, and in-house direct sales via proprietary and third-party e-commerce sites, targeting individual consumers seeking health and beauty solutions based on eggshell membrane biotechnology. Founded in 2000 and headquartered at 3-6-18 Kyobashi, 8F Tokyo Tatemono Kyobashi Building, Chuo-ku, Tokyo, Japan, Almado maintains a focused eggshell membrane healthcare segment with approximately 71 employees. Recent major changes encompass strategic ownership shifts including CBC Co Ltd's acquisition of an additional 10.26% stake in 2022 from Ant Capital Partners-managed funds, alongside ongoing research advancements and product promotions through key channels without noted new partnerships, funding rounds, or expansions in 2024-2025.